NCT03964168

Brief Summary

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 28, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 31, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2020

Completed
Last Updated

March 11, 2020

Status Verified

March 1, 2020

Enrollment Period

7 months

First QC Date

May 14, 2019

Last Update Submit

March 10, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine the most common reason for discontinuation

    Tally number of patients who discontinued due to adverse events, insurance issues or category other.

    5 years

Study Arms (1)

Biologic Therapy

Patient's who received and discontinued a biologic therapy

Drug: Biologic Agent

Interventions

Patients who discontinued a bioloic agent

Biologic Therapy

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male or female adults ≥ 18 years of age.

You may qualify if:

  • Male or female adults ≥ 18 years of age.
  • Was receiving first or second biologic therapy
  • Has not had a follow up with treating physician in ≥ 9 months

You may not qualify if:

  • Actively receiving biologic therapy
  • Was not receiving first or second biologic therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psoriasis Treatment Center of Central New Jersey

East Windsor, New Jersey, 08520, United States

Location

MeSH Terms

Conditions

Psoriasis

Interventions

Biological Factors

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2019

First Posted

May 28, 2019

Study Start

July 31, 2019

Primary Completion

March 3, 2020

Study Completion

March 3, 2020

Last Updated

March 11, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations